AA
FLNA

ALPS Advisors’s Filana Therapeutics FLNA Stock Holding History

ALPS Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-31,021
Closed -$516K – 1008
2023
Q3 		$516K Buy
31,021
+334
+1% +$6.62K ﹤0.01% 595
2023
Q2 		$752K Buy
30,687
+3,187
+12% +$76.8K 0.01% 544
2023
Q1 		$663K Sell
27,500
-806
-3% -$22.3K 0.01% 539
2022
Q4 		$836K Buy
+28,306
New +$1.02M 0.01% 515

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

ALPS Advisors's FLNA Position: Q4 2023 in Review

ALPS Advisors sold out of Filana Therapeutics (FLNA) in Q4 2023, closing a stake of 31,021 shares — an estimated $516K sold.

ALPS Advisors first reported a position in FLNA in Q4 2022 and held it in 4 quarters. The position peaked at $836K in Q4 2022. 153 funds tracked by Wall St. Rank hold FLNA as of Q4 2023.

  • ALPS Advisors reported no remaining Filana Therapeutics position as of Q4 2023 after selling out during the quarter.
  • ALPS Advisors sold 31,021 Filana Therapeutics shares in Q4 2023, an estimated $516K.
  • ALPS Advisors first reported a position in Filana Therapeutics in Q4 2022 and held it in 4 quarters.
  • ALPS Advisors's Filana Therapeutics position peaked at $836K in Q4 2022.
  • 153 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2023.

Based on ALPS Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.